Most Recent
A showdown between global pharmaceutical giants over the world's best selling vaccine began Monday in Federal Court, with Merck Sharp & Dohme claiming three patents for Prevnar 13 sold by Pfizer's Wyeth are invalid and that its own vaccine offers greater protection against pneumococcal bacteria.
Grain supplier Seednet has agreed to pay $1 million to settle an enforcement action by the consumer watchdog alleging it misled farmers about the performance of its latest barley variety.
Shareholder cases made up half of all class actions filed in the past two years, and are to blame for an "unprecedented spike" in class actions, according to a new report by a leading defence law firm.
A Queensland ethanol refinery, owned by United Petroleum, has lost a dispute with its insurer Allianz Australia over coverage for damage resulting from a 2016 fire.
Shareholders who registered for a class action against mining company MacMahon Holdings will get a $2.4 million cut of a proposed $6.7 million settlement, according to a notice sent to group members ahead of next week's settlement approval hearing.
Real estate advertiser REA Group has won an emergency injunction against Domain that blocks its rival from authorising the owner of the US website realestate.com to redirect Australian traffic to Domain.
A lingering dispute with the tax office remains, but the distribution of the record $795 million Black Saturday class actions settlement is substantially complete, according to a report out this week, and the proceedings, by the measure of at least one expert, show why the class action system in Australia is working.
IP owners need to consider the key or core licensing arrangements over the next six months and consider the competition law implications of conditions/restrictions in these licences, say Ayman Guirguis and David Howarth of K&L Gates.
Online real estate giant REA Group is suing competitor Domain Group over a referral arrangement with the US-based owner of the web address realestate.com, saying the deal amounts to trade mark infringement and misleading and deceptive conduct.
Generic drug maker Sandoz has been found liable for patent infringement and misleading and deceptive conduct in a case by pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro, ending a battle that has raged for 15 years.